Cue Biopharma Inc.
1.30
0.08 (6.56%)
At close: Jan 14, 2025, 3:59 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 5.49M 1.25M 14.94M 3.15M 3.46M 1.14M n/a n/a n/a
Cost of Revenue 38.10M 1.81M -1.78M 33.55M 27.49M 28.54M 419.57K 202.09K 44.81K
Gross Profit -32.61M -560.83K 16.72M -30.39M -24.03M -27.40M -419.57K -202.09K -44.81K
Operating Income -52.15M -53.22M -43.71M -45.04M -36.77M -38.70M -23.23M -7.66M -1.93M
Interest Income 2.66M 928.24K 45.90K 463.91K 419.00K 376.01K 35.00 52.00 n/a
Pretax Income -50.73M -53.01M -43.67M -44.58M -36.29M -38.16M -23.23M -7.66M -1.93M
Net Income -50.73M -52.80M -44.16M -44.78M -36.70M -38.98M -23.23M -7.66M -1.93M
Selling & General & Admin 16.68M 16.17M 17.31M 14.65M 12.74M 11.30M 4.33M 1.97M 425.08K
Research & Development 40.80M 38.58M 41.35M 33.55M 27.49M 28.54M 18.90M 5.69M 1.50M
Other Expenses -37.94M n/a n/a n/a 64.00K 165.34K n/a n/a n/a
Operating Expenses 19.54M 54.75M 58.65M 48.20M 40.23M 39.84M 23.23M 7.66M 1.93M
Interest Expense 1.25M 713.82K n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 57.64M 54.75M 58.65M 48.20M 40.23M 39.84M 23.23M 7.66M 1.93M
Income Tax n/a -214.43K 495.00K 206.25K 412.00K 825.00K n/a n/a n/a
Shares Outstanding (Basic) 45.75M 35.65M 31.29M 28.69M 22.04M 20.13M 20.64M 20.64M 20.64M
Shares Outstanding (Diluted) 45.75M 35.65M 31.29M 28.69M 22.04M 20.13M 20.64M 20.64M 20.64M
EPS (Basic) -1.11 -1.48 -1.41 -1.56 -1.66 -1.94 -1.13 -0.37 -0.09
EPS (Diluted) -1.11 -1.48 -1.41 -1.56 -1.66 -1.94 -1.13 -0.37 -0.09
EBITDA -46.05M -50.49M -45.44M -43.99M -35.96M -37.94M -22.81M -7.46M -1.88M
Depreciation & Amortization 3.44M 1.81M -1.78M 1.06M 5.35M 760.01K 419.57K 202.09K 44.81K

Create Price Alert on CUE

Your price alert will notify you when the stock price is above 1.30.

Add to Watchlist